Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
Conditions: Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Relapsed Pediatric Solid Tumor; Refractory Pediatric Solid Tumor; Melanoma; Hepatoblastoma; Hepatocellular Carcinoma; Neuroblastoma; Wilms Tumor Interventions: Procedure: Cryoablation Therapy; Drug: Nivolumab; Drug: Ipilimumab Sponsors: Children's National Research Institute; Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Brain | Cancer & Oncology | Carcinoma | Children | Hepatoblastoma | Melanoma | Neoadjuvant Therapy | Neuroblastoma | Neurology | Osteosarcoma | Pediatrics | Research | Rhabdomyosarcoma | Sarcomas | Skin Cancer | Yervoy